Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Mapi Pharma Ltd.

Clinical trials sponsored by Mapi Pharma Ltd., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New monthly shot could simplify mental health treatment Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 2 Completed 1 Terminated 1

Can a Once-a-Month shot tame MS relapses?

Disease control Completed

This phase III trial is testing whether a long-acting form of glatiramer acetate, called GA Depot, given as a monthly injection, can reduce the number of relapses in people with relapsing-remitting multiple sclerosis (MS). The study involves about 1,000 adults aged 18 to 55 with …

Phase 3 • Sponsor: Mapi Pharma Ltd. • Aim: Disease control

Last updated Aug 07, 2026 00:00 UTC